n-Ethyl-2,2-diisopropylbutanamide
Common Name: |
n-Ethyl-2,2-diisopropylbutanamide |
IUPAC Name: |
N,2-diethyl-3-methyl-2-propan-2-ylbutanamide |
Molecular Formula: |
C12H18O2 |
SMILES: |
CCC(C(C)C)(C(C)C)C(=O)NCC |
Inchi: |
1S/C12H25NO/c1-7-12(9(3)4,10(5)6)11(14)13-8-2/h9-10H,7-8H2,1-6H3,(H,13,14) |
Inchi Key: |
PCOMMNVANAQDMV-UHFFFAOYSA-N |
Cas No: |
51115-70-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
194.27 |
Mass (g/mol) |
199.194 |
Molar Refractivity |
58.02 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
3 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
36.00 to 40.00 |
Boiling Point (°C@760.00mm Hg) |
258.00 to 259.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.013 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.58 |
LogP |
2.831 |
iLOGP |
2.90 |
XLOGP3 |
2.87 |
WLOGP |
2.85 |
MLOGP |
2.56 |
ESOL Log S |
-2.65 |
ESOL Solubility (mg/ml) |
0.43 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.08 |
Ali Solubility (mg/ml) |
0.16 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.39 |
Silicos-IT Solubility (mg/ml) |
0.8 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.45 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.389 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.043 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |